Kyongbo Pharmaceutical Co Ltd
KRX:214390
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| KR |
|
Kyongbo Pharmaceutical Co Ltd
KRX:214390
|
136.5B KRW |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
574.1B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
283.4B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.9B USD |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
231.1B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.8B GBP |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124B USD |
Loading...
|
Market Distribution
| Min | -168 471.3% |
| 30th Percentile | -2.9% |
| Median | 1.9% |
| 70th Percentile | 5.8% |
| Max | 21 012.5% |
Other Profitability Ratios
Kyongbo Pharmaceutical Co Ltd
Glance View
KYONGBO PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Asan, Chungcheongnam-Do. The company went IPO on 2015-06-29. The firm distributes its products within domestic market and to overseas markets including China Japan and Europe.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Kyongbo Pharmaceutical Co Ltd is 0.9%, which is below its 3-year median of 1.2%.
Over the last 3 years, Kyongbo Pharmaceutical Co Ltd’s Net Margin has increased from -2.2% to 0.9%. During this period, it reached a low of -2.2% on Aug 30, 2022 and a high of 2.3% on Mar 31, 2024.
